You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 12, December 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Statistics and Research Methods
 •Randomized Controlled Trial
 •Ophthalmological Disorders, Other
 •Patient-Physician Relationship/ Care
 •Treatment Adherence
 •Drug Therapy
 •Adherence
 •Alert me on articles by topic

Convergence Insufficiency: Randomized Clinical Trial—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In reply

We are pleased to read that Dr Jethani values our past and ongoing efforts to investigate the effectiveness of vision therapy using rigorous scientific methodology and welcome the opportunity to respond to the issues raised in his letter.

He expressed concern that there was a great disparity in treatment time or dosage between home-based pencil push-ups and office-based vision therapy/orthoptics and calculated a difference of 60 hours between the 2 groups. His calculations are inaccurate. The home-based pencil push-ups group performed 15 minutes of treatment, 5 days per week. This yielded 75 minutes of treatment per week for 12 weeks or 15 total hours. The office-based vision therapy/orthoptics group also performed 15 hours of home therapy over the course of 12 weeks, but also received 12 hours of office-based treatment (1 hour per week) for a total of 27 hours; not the 75 hours incorrectly calculated by Dr . . . [Full Text of this Article]


AUTHOR INFORMATION
Mitchell Scheiman, OD; G. Lynn Mitchell, MS; Susan Cotter, OD; Jeffrey Cooper, OD, MS; Marjean Kulp, OD, MS; Michael Rouse, OD, MS; Eric Borsting, OD, MS; Richard London, MS, OD; Janice Wensveen, OD, PhD; the Convergence Insufficiency Treatment Trial (CITT) Study Group


RELATED ARTICLE

Convergence Insufficiency: Randomized Clinical Trial
Jitendra Jethani
Arch Ophthalmol. 2005;123(12):1760.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.